Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Hit record highs
Diagnosed with cancer
To speak at RNC convention
'Candid Camera' star dies
Lead investigator suspended
Ruling in 'Rust' hearing
Bloomberg donates $1B
'General Hospital' actor dies
Columbia removes 3 deans
‘Rotten egg’ atmosphere
Violent holiday weekend
No Parkinson's treatments
Pleads guilty in Jan. 6 attack
Tire flies off during takeoff
13 missing hikers found
Neverland Ranch threatened
VP pick likely this week
Military land deals review
RNC's new abortion stance
$50M deal with UConn
Sentinel ICBM cost grows
Cape Town homes destroyed
Higher education survey
TSA sets screening record
Olympic roster announced
Napoleon’s pistols sold
NASCAR launches probe
New bird flu study
Beryl claims 6 lives
Inspections over mask issue
Fritz reaches quarterfinals
'Put his power up for sale'
Settles antisemitism suit
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Ozempic and Cancer Risks
What to know about new study showing weight loss drugs can lower cancer risk
Clinical studies show users of the medications can lose between 5% and 20% of their body weight over time. The study authors wrote that more research is needed to determine exactly how and why GLP-1 drugs may contribute to a lower risk of obesity-associated cancers.
Ozempic and Related Drugs May Reduce Cancer Risks, Study Claims
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
Healthline
3d
GLP-1 Drugs Like Ozempic May Reduce Risk of These 10 Cancers
Share on Pinterest A study finds that people with type 2 diabetes who took semaglutide were less likely to develop certain ...
The American Journal of Managed Care
3d
GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Wegovy
Feedback